gefitinib has been researched along with tg 003 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (tg 003) | Trials (tg 003) | Recent Studies (post-2010) (tg 003) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 45 | 0 | 33 |
| Protein | Taxonomy | gefitinib (IC50) | tg 003 (IC50) |
|---|---|---|---|
| Dual specificity protein kinase CLK2 | Mus musculus (house mouse) | 0.2 | |
| Dual specificity protein kinase CLK4 | Mus musculus (house mouse) | 0.015 | |
| Dual specificity protein kinase CLK1 | Mus musculus (house mouse) | 0.02 | |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | 0.064 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.6172 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Mus musculus (house mouse) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for gefitinib and tg 003
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |